315 related articles for article (PubMed ID: 19117025)
21. Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer.
Pal T; Akbari MR; Sun P; Lee JH; Fulp J; Thompson Z; Coppola D; Nicosia S; Sellers TA; McLaughlin J; Risch HA; Rosen B; Shaw P; Schildkraut J; Narod SA
Br J Cancer; 2012 Nov; 107(10):1783-90. PubMed ID: 23047549
[TBL] [Abstract][Full Text] [Related]
22. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
23. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
[TBL] [Abstract][Full Text] [Related]
24. High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country.
Martínez-Bouzas C; Ojembarrena E; Beristain E; Errasti J; Viguera N; Tejada Minguéz MI
Cancer Lett; 2007 Oct; 255(2):295-9. PubMed ID: 17582678
[TBL] [Abstract][Full Text] [Related]
25. Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study.
Park JG; Kim DW; Hong CW; Nam BH; Shin YK; Hong SH; Kim IJ; Lim SB; Aronson M; Bisgaard ML; Brown GJ; Burn J; Chow E; Conrad P; Douglas F; Dunlop M; Ford J; Greenblatt MS; Heikki J; Heinimann K; Lynch EL; Macrae F; McKinnon WC; Möeslein G; Rossi BM; Rozen P; Schofield L; Vaccaro C; Vasen H; Velthuizen M; Viel A; Wijnen J;
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3389-93. PubMed ID: 16740762
[TBL] [Abstract][Full Text] [Related]
26. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer.
Mangold E; Pagenstecher C; Friedl W; Mathiak M; Buettner R; Engel C; Loeffler M; Holinski-Feder E; Müller-Koch Y; Keller G; Schackert HK; Krüger S; Goecke T; Moeslein G; Kloor M; Gebert J; Kunstmann E; Schulmann K; Rüschoff J; Propping P
Int J Cancer; 2005 Sep; 116(5):692-702. PubMed ID: 15849733
[TBL] [Abstract][Full Text] [Related]
27. Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds.
Grindedal EM; Renkonen-Sinisalo L; Vasen H; Evans G; Sala P; Blanco I; Gronwald J; Apold J; Eccles DM; Sánchez AA; Sampson J; Järvinen HJ; Bertario L; Crawford GC; Stormorken AT; Maehle L; Moller P
J Med Genet; 2010 Feb; 47(2):99-102. PubMed ID: 19635727
[TBL] [Abstract][Full Text] [Related]
28. Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States.
Kastrinos F; Stoffel EM; Balmaña J; Steyerberg EW; Mercado R; Syngal S
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2044-51. PubMed ID: 18708397
[TBL] [Abstract][Full Text] [Related]
29. Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway.
Llor X; Pons E; Xicola RM; Castells A; Alenda C; Piñol V; Andreu M; Castellví-Bel S; Payá A; Jover R; Bessa X; Girós A; Roca A; Gassull MA;
Clin Cancer Res; 2005 Oct; 11(20):7304-10. PubMed ID: 16243801
[TBL] [Abstract][Full Text] [Related]
30. Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome.
Alvarez K; Hurtado C; Hevia MA; Wielandt AM; de la Fuente M; Church J; Carvallo P; López-Köstner F
Dis Colon Rectum; 2010 Apr; 53(4):450-9. PubMed ID: 20305446
[TBL] [Abstract][Full Text] [Related]
31. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H
J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
[TBL] [Abstract][Full Text] [Related]
33. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.
Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E
Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471
[TBL] [Abstract][Full Text] [Related]
34. MLH1 and MSH2 mutation screening in HNPCC families of Hungary - Two new MMR gene mutations.
Tanyi M; Olasz J; Tanyi JL; Tóth L; Antal-Szalmás P; Ress Z; Bubán T; Palatka K; András C; Urbancsek H; Garami Z; Csuka O; Damjanovich L
Eur J Surg Oncol; 2014 Nov; 40(11):1445-52. PubMed ID: 25107687
[TBL] [Abstract][Full Text] [Related]
35. A new strategy to screen MMR genes in Lynch Syndrome: HA-CAE, MLPA and RT-PCR.
Perez-Cabornero L; Velasco E; Infante M; Sanz D; Lastra E; Hernández L; Miner C; Duran M
Eur J Cancer; 2009 May; 45(8):1485-93. PubMed ID: 19250818
[TBL] [Abstract][Full Text] [Related]
36. [The analysis for mRNA mutation of MLH1, MSH2 genes and the gene diagnosis for hereditary nonpolyposis colorectal cancer].
Wang CF; Zhou XY; Zhang TM; Sun MH; Xu Y; Shi DR
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):32-6. PubMed ID: 16456782
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
[TBL] [Abstract][Full Text] [Related]
38. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
[TBL] [Abstract][Full Text] [Related]
39. Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia.
Lee SC; Guo JY; Lim R; Soo R; Koay E; Salto-Tellez M; Leong A; Goh BC
Clin Genet; 2005 Aug; 68(2):137-45. PubMed ID: 15996210
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer.
Limburg PJ; Harmsen WS; Chen HH; Gallinger S; Haile RW; Baron JA; Casey G; Woods MO; Thibodeau SN; Lindor NM
Clin Gastroenterol Hepatol; 2011 Jun; 9(6):497-502. PubMed ID: 21056691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
